dr. Farid Kurniawan, Sp.PD, PhD

• Spesialis Penyakit Dalam

• 2019-2023: PhD, Leiden University Medical Center, Leiden, The Netherlands
• 2010-2015: Internal Medicine Specialist, Faculty of Medicine, Universitas Indonesia, Jakarta
• 2005-2007: Medical Doctor, Faculty of Medicine, Universitas Indonesia, Jakarta
• 2001-2005: Bachelor of Medical Science, Faculty of Medicine, Universitas Indonesia, Jakarta

Training/Courses/Symposium

• 2023, Jakarta Endocrine Meeting 2023, Jakarta, Indonesia
• 2023, The 1st International Conference on Cardiovascular, Metabolic, and Aging Research Symposium (C-MARS) 2023: Japan, Netherlands, and Indonesia Collaboration  
• 2022, Clinical Observership, Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands
• 2022, Jakarta Diabetes Meeting 2022, Jakarta, Indonesia
• 2022, Forum Endokrinologi Nasional X dan PIT PERKENI 2022
• 2022, European Congress on Obesity, Maastricht, The Netherlands
• 2021, ENDO Conference 2021, USA    
• 2019, The 19th International Society of Diabetic Foot Congress, The Hague, The Netherlands
• 2018, The 12th IDF-WPR Congress and 10th AASD Scientific Meeting in Kuala Lumpur, Malaysia
• 2018, Thyroid Ultrasound Workshop, World Congress of Internal Medicine (WCIM), Bali, Indonesia
• 2018, Summer Academy on Urban Transtitions held by UI, UGM and Leiden University in Depok, West Jawa, Indonesia 
• 2016, Cellular Therapy Half-minor Course, Leiden University Medical Center, The Netherlands
• 2016, EMSS-Mayo Course in Advanced Endocrinology, Singapore

Organization

• European Association for the Study of Obesity (EASO)
• The Endocrine Society
• Perkumpulan Endokrinologi Indonesia (PERKENI)
• Indonesian Thyroid Association (INATA)
• Himpunan Studi Obesitas Indonesia (HISOBI)/Indonesian Society for the Study of Obesity (ISSO)
• Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (PAPDI)

Publication

• Tahapary DL, Fatya AI, Kurniawan F, Marcella C, Rinaldi I, Tarigan THE, Harbuwono DS, Yunir E, Soewondo P, Purnamasari D. Increased intestinal fatty acid binding protein in obesity-associated type 2 diabetes mellitus. PLosOne. 2023;18(1): e0279915.
• Kurniawan F, Manurung MD, Harbuwono DS, Yunir E, Tsonaka R, Pradnjaparamita T, Vidiawati D, Anggunadi A, Soewondo P, Yazdanbakhsh M, Sartono E, Tahapary DL. Urbanization and unfavorable changes in metabolic profiles: a prospective cohort study of Indonesian young adults. Nutrients. 2023;14(16):3326
• Harbuwono DS, Sazli BI, Kurniawan F, Darmowidjojo B, Koesno S, Tahapary DL. The impact of Ramadan fasting on Fetuin-A level in type 2 diabetes mellitus. Heliyon. 2021;7(5):e06773.
• Yunir E, Kurniawan F, Rezaprasga E, Wijaya IP, Suroyo I, Matondang S, et al. Autologus bone-marrow vs. peripheral blood mononuclear cells therapy for peripheral artery disease in diabetics patients. Int J Stem Cells. 2021;14(1):21-32.
• Kurniawan F, Tahapary DL, de Ruiter K, Yunir E, Biermasz NR, Smit JWA, et al. Effect of anthelmintic treatment on serum free IGF-1 and IGFBP-3: a cluster-randomized-controlled trial in Indonesia. Sci Rep. 2020;10:19023.
• Harbuwono DS, Kurniawan F, Sudarsono NC, Tahapary DL. The impact of Ramadan fasting on glucose variability in type 2 diabetes mellitus patients on oral anti diabetic agents. PLoS ON. 2020;15(6):e0234443.
• Tahapary DL, de Ruiter K, Kurniawan F, Djuardi T, Wang Y, Nurdin SME, et al. Impact of rural-urban environment on metabolic profile and response to a 5-day high-fat diet. Sci Rep 2018;8:8149.